Overall rank by patents
#626
Across all tracked assignees
USPTO PatentsView assignee record - 709 granted patents across 150 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
NEW holds 709 US patents across 150 technology areas, rank #626 of 50,000 tracked assignees.
NEW YORK University has been granted 709 US utility patents between 2015 and 2025, placing NEW YORK University at rank #626 across all assignees tracked by PlainPatent. This portfolio spans 150 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, NEW YORK University is one of the broader-portfolio assignees in the PatentsView dataset. By volume, NEW sits between Eastman Kodak Company (711 patents, rank #622) and Arista Networks, Inc. (706 patents, rank #630) - the closest US assignees by grant volume. The composite Innovation Score of 63.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 301 grants, compared with 408 in the 2015–2019 window, a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. NEW YORK University's 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark NEW YORK University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EASTMAN KODAK COMPANY
711 patents
Johnson Controls Tyco IP Holdings LLP
710 patents
VIAVI Solutions Inc.
710 patents
CJ CHEILJEDANG CORPORATION
709 patents
NEW YORK UNIVERSITY
709 patents
Allegro MicroSystems, LLC
708 patents
Dexcom, Inc.
708 patents
KRONES AG
708 patents
Arista Networks, Inc.
706 patents
What this shows NEW holds 709 patents at rank #626, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #626 in granted patent volume.
Other assignees with the most granted patents in NEW's primary technology class.
NEW's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 66 | 9.3% |
| 2016 | 98 | 13.8% |
| 2017 | 97 | 13.7% |
| 2018 | 75 | 10.6% |
| 2019 | 72 | 10.2% |
| 2020 | 74 | 10.4% |
| 2021 | 54 | 7.6% |
| 2022 | 49 | 6.9% |
| 2023 | 48 | 6.8% |
| 2024 | 49 | 6.9% |
| 2025 | 27 | 3.8% |
Top 15 of 150 technology areas
Overall rank by patents
#626
Across all tracked assignees
63.1 out of 100
How to use this portfolio
NEW's 709 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.